Tiny Health Raises $33M To Explore What Gut Data Can Reveal About Future Health
Austin-based Tiny Health has raised $33 million in a Series B funding round led by B Capital to help it meet growing demand for its at-home microbiome tests.
Cheryl Sew Hoy co-founded Tiny Health, an Austin-based company that raised $33 million in a Series B funding round led by B Capital. The company focuses on analyzing the microbiome of infants and adults through at-home tests. Sew Hoy's daughter developed eczema, allergies and food sensitivities after being born by C-section, leading her to research the infant gut microbiome and start Tiny Health.
The company's tests use shotgun metagenomic sequencing for a broader view of microbial DNA compared to other tests. Tiny Health's revenue has doubled each year, and the company's growth is fueled by both its consumer-facing tests and its B2B arm, Powered by Tiny, which sells tests to healthcare providers and wellness companies. The company's tests provide actionable, evidence-backed insights into microbial health, but do not establish a cause for symptoms and are not covered by insurance.
Written by urgent.news from Crunchbase News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
